Firm targets 3D printing synthetic tissues, organs

April 17, 2014, Oxford University
Firm targets 3D printing synthetic tissues, organs
Prototype droplet network printer built by Oxford scientists. Credit: OU/G Villar

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company aims to print synthetic tissues for organ repair or replacement. 

Isis Innovation, the University's research commercialisation company, announced today that OxSyBio has raised £1 million from IP Group plc, the developer of intellectual property based businesses, subject to the achievement of milestones. The new company will refine and advance the 3D droplet printing technology devised by Professor Hagan Bayley's group at Oxford University's Department of Chemistry. 

Professor Bayley's group has developed a technique to print synthetic tissue-like materials from thousands of tiny water droplets each coated in a thin film mimicking a living cell's external membrane, and studding these membranes with protein pores so they act like simplified cells. The group's research was featured on the cover page of Science in April 2013.

Professor Hagan Bayley said: 'We have been able to print networks of droplets through which electrical impulses can be transmitted in a manner similar to the way cells in the nervous system communicate: the signal moves rapidly and in a specific direction. We also aim to integrate printed tissue-like materials with living tissues, and to print materials that themselves contain living cells. 

Credit: Oxford University

'Our long-term goal is to develop a synthetic-tissue printer that a surgeon can use in the operating theatre. In ten years' time, the use of pieces of synthetic tissue will be commonplace. The fabrication of complex synthetic organs is a more distant prospect.

'I am delighted to be working with Isis and IP Group to accelerate the development of our new company, OxSyBio. Our goal is to establish ourselves at the frontline of regenerative medicine.'

Tom Hockaday, managing director of Isis Innovation, said: 'This is the type of technology where science fiction can become science fact and Isis is proud to have been involved in creating a company around Professor Bayley's vision.'

Alan Aubrey, Chief Executive Officer of IP Group, said: 'Synthetic biology and regenerative medicine will be central to the development of healthcare in the 21st century and IP Group is pleased to support OxSyBio as it seeks to develop products that will help to realise the potential of these exciting and growing areas.' 

Explore further: Bioprinting new organs

Related Stories

Bioprinting new organs

April 3, 2014
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.

New technology allows vital signs to be checked via webcam

September 20, 2012
Webcam software developed by a new Oxford University spin-out company will offer a simple, non-invasive way of monitoring patients' vital signs.

Recommended for you

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.